| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Found 13 studies with search of: | "Pirfenidone" |
|
Hide studies that are not seeking new volunteers.
|
|
| 1 | Recruiting | Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome | ||||
| Conditions: | Albinism; Inborn Errors of Metabolism; Oculocutaneous Albinism; Platelet Storage Pool Deficiency; Pulmonary Fibrosis | |||||
| Interventions: | Drug: Pirfenidone (Deskar); Drug: Pirfenidone | |||||
| 2 | Active, not recruiting | Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis) | ||||
| Conditions: | Fibrosis; Focal Glomerulosclerosis; Kidney Failure; Nephrotic Syndrome; Proteinuria | |||||
| Intervention: | Drug: Pirfenidone | |||||
| 3 | Active, not recruiting | Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis | ||||
| Condition: | Idiopathic Pulmonary Fibrosis | |||||
| Intervention: | Drug: Pirfenidone | |||||
| 4 | Active, not recruiting | Three-Arm Study of the Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis | ||||
| Condition: | Idiopathic Pulmonary Fibrosis | |||||
| Intervention: | Drug: Pirfenidone | |||||
| 5 | Completed | Pirfenidone to Treat Hypertrophic Cardiomyopathy | ||||
| Condition: | Hypertrophic Cardiomyopathy | |||||
| Intervention: | Drug: Pirfenidone | |||||
| 6 | Enrolling by invitation | Open-Label Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF) | ||||
| Condition: | Idiopathic Pulmonary Fibrosis | |||||
| Intervention: | Drug: pirfenidone | |||||
| 7 | Completed | Pirfenidone to Treat Kidney Disease in Patients With Diabetes | ||||
| Conditions: | Diabetic Nephropathies; Diabetes Type 1; Diabetes Type 2; Diabetic Kidney Disease | |||||
| Intervention: | Drug: Pirfenidone | |||||
| 8 | Recruiting | Pirfenidone: A New Drug to Treat Kidney Disease in Patients With Diabetes | ||||
| Conditions: | Diabetes Mellitus; Diabetic Nephropathy | |||||
| Intervention: | Drug: Pirfenidone | |||||
| 9 | Completed | Pirfenidone in Treating Patients With Fibrosis Caused by Radiation Therapy for Cancer | ||||
| Condition: | Radiation Fibrosis | |||||
| Intervention: | Drug: pirfenidone | |||||
| 10 | Completed | Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas | ||||
| Conditions: | Neurofibromatosis Type 1 (nf1); Precancerous/Nonmalignant Condition | |||||
| Intervention: | Drug: pirfenidone | |||||
| 11 | Recruiting | Pirfenidone in Treating Young Patients With Neurofibromatosis Type I and Recurrent or Progressive Plexiform Neurofibromas | ||||
| Conditions: | Neurofibromatosis Type 1 (nf1); Precancerous/Nonmalignant Condition | |||||
| Intervention: | Drug: pirfenidone | |||||
| 12 | Active, not recruiting | Pirfenidone for the Treatment of Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis (PF/IPF) | ||||
| Conditions: | Idiopathic Pulmonary Fibrosis; Pulmonary Fibrosis | |||||
| Intervention: | Drug: Pirfenidone | |||||
| 13 | Completed | Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids) | ||||
| Conditions: | Uterine Leiomyoma; Fibroids | |||||
| Intervention: | Drug: Pirfenidone | |||||
|
